$RMCF
Rocky Mountain Chocolate Factory, Inc.

2020 Q2 Form 10-Q Financial Statement

#000143774920015388 Filed on July 20, 2020

View on sec.gov

Income Statement

Concept 2020 Q2 2019 Q2
Revenue $2.702M $8.426M
YoY Change -67.93% 0.72%
Cost Of Revenue $2.883M $4.615M
YoY Change -37.52% -1.08%
Gross Profit -$561.0K $1.846M
YoY Change -130.39% -3.7%
Gross Profit Margin -20.76% 21.91%
Selling, General & Admin $3.654M $1.701M
YoY Change 114.74% 13.22%
% of Gross Profit 92.17%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $343.1K $377.7K
YoY Change -9.15% -13.68%
% of Gross Profit 20.46%
Operating Expenses $3.654M $1.701M
YoY Change 114.74% 13.22%
Operating Profit -$4.829M $946.0K
YoY Change -610.46% 20.78%
Interest Expense $23.56K $12.40K
YoY Change 90.05% -45.24%
% of Operating Profit 1.31%
Other Income/Expense, Net -$17.76K -$2.219K
YoY Change 700.45% -87.71%
Pretax Income -$4.847M $943.8K
YoY Change -613.54% 23.34%
Income Tax -$1.179M $232.2K
% Of Pretax Income 24.6%
Net Earnings -$3.667M $711.6K
YoY Change -615.37% 23.34%
Net Earnings / Revenue -135.71% 8.45%
Basic Earnings Per Share -$0.61 $0.12
Diluted Earnings Per Share -$0.61 $0.11
COMMON SHARES
Basic Shares Outstanding 6.059M 5.962M
Diluted Shares Outstanding 6.059M 6.235M

Balance Sheet

Concept 2020 Q2 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $7.440M $5.900M
YoY Change 26.1% -6.35%
Cash & Equivalents $7.441M $5.896M
Short-Term Investments
Other Short-Term Assets $397.3K $440.2K
YoY Change -9.74% -8.11%
Inventory $4.141M $4.016M
Prepaid Expenses
Receivables $2.321M $3.877M
Other Receivables $420.0K $0.00
Total Short-Term Assets $14.83M $14.37M
YoY Change 3.16% -6.67%
LONG-TERM ASSETS
Property, Plant & Equipment $5.704M $5.855M
YoY Change -2.59% -2.46%
Goodwill $729.7K $1.047M
YoY Change -30.3% 0.0%
Intangibles $479.6K
YoY Change -15.09%
Long-Term Investments
YoY Change
Other Assets $56.26K $63.38K
YoY Change -11.23% -11.5%
Total Long-Term Assets $14.28M $15.17M
YoY Change -5.89% 125.35%
TOTAL ASSETS
Total Short-Term Assets $14.83M $14.37M
Total Long-Term Assets $14.28M $15.17M
Total Assets $29.11M $29.55M
YoY Change -1.49% 5.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.965M $1.126M
YoY Change 163.22% -20.94%
Accrued Expenses $1.880M $1.860M
YoY Change 1.08% 64.6%
Deferred Revenue $193.5K $238.2K
YoY Change -18.77% -18.16%
Short-Term Debt $3.450M $0.00
YoY Change
Long-Term Debt Due $590.0K $829.9K
YoY Change -28.91% -39.22%
Total Short-Term Liabilities $9.679M $5.482M
YoY Change 76.57% -3.49%
LONG-TERM LIABILITIES
Long-Term Debt $950.0K
YoY Change
Other Long-Term Liabilities $2.650M $3.450M
YoY Change -23.19% 208.04%
Total Long-Term Liabilities $3.600M $0.00
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $9.679M $5.482M
Total Long-Term Liabilities $3.600M $0.00
Total Liabilities $13.28M $5.482M
YoY Change 142.26% -15.8%
SHAREHOLDERS EQUITY
Retained Earnings $8.222M $13.73M
YoY Change -40.11% -3.41%
Common Stock $7.610M $6.888M
YoY Change 10.48% 9.46%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $15.83M $20.62M
YoY Change
Total Liabilities & Shareholders Equity $29.11M $29.55M
YoY Change -1.49% 5.01%

Cashflow Statement

Concept 2020 Q2 2019 Q2
OPERATING ACTIVITIES
Net Income -$3.667M $711.6K
YoY Change -615.37% 23.34%
Depreciation, Depletion And Amortization $343.1K $377.7K
YoY Change -9.15% -13.68%
Cash From Operating Activities -$1.598M $1.828M
YoY Change -187.42% 33.03%
INVESTING ACTIVITIES
Capital Expenditures $22.49K $283.5K
YoY Change -92.07% 117.16%
Acquisitions
YoY Change
Other Investing Activities -$312.00
YoY Change -105.81%
Cash From Investing Activities -$46.13K -$254.8K
YoY Change -81.9% 150.48%
FINANCING ACTIVITIES
Cash Dividend Paid $722.3K $715.2K
YoY Change 1.0% 0.92%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $346.5K
YoY Change 3.77%
Cash From Financing Activities 4.263M -1.062M
YoY Change -501.52% 1.83%
NET CHANGE
Cash From Operating Activities -1.598M 1.828M
Cash From Investing Activities -46.13K -254.8K
Cash From Financing Activities 4.263M -1.062M
Net Change In Cash 2.619M 511.5K
YoY Change 411.95% 122.51%
FREE CASH FLOW
Cash From Operating Activities -$1.598M $1.828M
Capital Expenditures $22.49K $283.5K
Free Cash Flow -$1.621M $1.545M
YoY Change -204.92% 24.19%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q2 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
2618852
CY2019Q2 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
511547
CY2020Q2 dei Amendment Flag
AmendmentFlag
false
CY2020Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--02-28
CY2020Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2020Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2020Q2 dei Document Period End Date
DocumentPeriodEndDate
2020-05-31
CY2020Q2 dei Document Type
DocumentType
10-Q
CY2020Q2 dei Entity Central Index Key
EntityCentralIndexKey
0001616262
CY2020Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
6065138
CY2020Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020Q2 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2020Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q2 dei Entity Registrant Name
EntityRegistrantName
Rocky Mountain Chocolate Factory, Inc.
CY2020Q2 dei Entity Shell Company
EntityShellCompany
false
CY2020Q2 dei Entity Small Business
EntitySmallBusiness
true
CY2020Q2 dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value per share; Preferred Stock Purchase Rights
CY2020Q2 dei Trading Symbol
TradingSymbol
rmcf
CY2020Q2 rmcf Amortized Gain On The Financed Sale Of Equipment
AmortizedGainOnTheFinancedSaleOfEquipment
1043
CY2019Q2 rmcf Amortized Gain On The Financed Sale Of Equipment
AmortizedGainOnTheFinancedSaleOfEquipment
3133
CY2020Q2 rmcf Assets Noncurrent Other Than Property Plant And Equipment
AssetsNoncurrentOtherThanPropertyPlantAndEquipment
8576298
CY2020Q1 rmcf Assets Noncurrent Other Than Property Plant And Equipment
AssetsNoncurrentOtherThanPropertyPlantAndEquipment
8267645
CY2020Q2 rmcf Contract With Customer Liability Contract Fees Received
ContractWithCustomerLiabilityContractFeesReceived
27500
CY2019Q2 rmcf Contract With Customer Liability Contract Fees Received
ContractWithCustomerLiabilityContractFeesReceived
16032
CY2020Q2 rmcf Customers Contracts Term
CustomersContractsTerm
P10Y
CY2020Q2 rmcf Gift Card Liability Current
GiftCardLiabilityCurrent
605437
CY2020Q1 rmcf Gift Card Liability Current
GiftCardLiabilityCurrent
609842
CY2020Q2 rmcf Intangible Assets Accumulated Amortization
IntangibleAssetsAccumulatedAmortization
4145034
CY2020Q1 rmcf Intangible Assets Accumulated Amortization
IntangibleAssetsAccumulatedAmortization
3996477
CY2020Q2 rmcf Intangible Assets Gross
IntangibleAssetsGross
8212306
CY2020Q1 rmcf Intangible Assets Gross
IntangibleAssetsGross
8589502
CY2020Q2 rmcf Intangible Assets Net Excluding Goodwill And Franchise Rights Total
IntangibleAssetsNetExcludingGoodwillAndFranchiseRightsTotal
421864
CY2020Q1 rmcf Intangible Assets Net Excluding Goodwill And Franchise Rights Total
IntangibleAssetsNetExcludingGoodwillAndFranchiseRightsTotal
498393
CY2020Q2 rmcf Inventory Packaging
InventoryPackaging
42086
CY2020Q1 rmcf Inventory Packaging
InventoryPackaging
56708
CY2015Q1 rmcf Stock Repurchase Program Additional Authorized Amount
StockRepurchaseProgramAdditionalAuthorizedAmount
2058000
CY2015Q2 rmcf Stock Repurchase Program Additional Authorized Amount
StockRepurchaseProgramAdditionalAuthorizedAmount
2090000
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
2965103
CY2020Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
2241506
CY2020Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2320580
CY2020Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4049959
CY2020Q2 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
779037
CY2020Q1 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
716860
CY2020Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
12543081
CY2020Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
12719338
CY2020Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
7603608
CY2020Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
7459931
CY2020Q2 us-gaap Additions To Other Assets Amount
AdditionsToOtherAssetsAmount
22488
CY2019Q2 us-gaap Additions To Other Assets Amount
AdditionsToOtherAssetsAmount
283548
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
143718
CY2019Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
231254
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1908912
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
638907
CY2020Q2 us-gaap Allowance For Notes And Loans Receivable Current
AllowanceForNotesAndLoansReceivableCurrent
50814
CY2020Q1 us-gaap Allowance For Notes And Loans Receivable Current
AllowanceForNotesAndLoansReceivableCurrent
0
CY2020Q2 us-gaap Allowance For Notes And Loans Receivable Noncurrent
AllowanceForNotesAndLoansReceivableNoncurrent
149186
CY2020Q1 us-gaap Allowance For Notes And Loans Receivable Noncurrent
AllowanceForNotesAndLoansReceivableNoncurrent
0
CY2020Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
148557
CY2019Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
176544
CY2020Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
544801
CY2020Q2 us-gaap Assets
Assets
29108126
CY2019Q2 us-gaap Assets
Assets
29548443
CY2020Q1 us-gaap Assets
Assets
27817388
CY2020Q2 us-gaap Assets Current
AssetsCurrent
14828244
CY2020Q1 us-gaap Assets Current
AssetsCurrent
13611730
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7440923
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4822071
CY2019Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5384027
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5895574
CY2020Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.12
CY2019Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.12
CY2019Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.12
CY2019Q4 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.12
CY2020Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.12
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
46000000
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
46000000
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6060663
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6019532
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6060663
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6019532
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
6061
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
6020
CY2020Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1155809
CY2019Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1352572
CY2020Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1127250
CY2019Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1259191
CY2020Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
193492
CY2020Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
195658
CY2020Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
933758
CY2020Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
960151
CY2020Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
55016
CY2019Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
106280
CY2020Q2 us-gaap Contractual Obligation
ContractualObligation
227000
CY2020Q2 us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
157510
CY2019Q2 us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
145699
CY2020Q2 us-gaap Cost Of Revenue
CostOfRevenue
2883216
CY2019Q2 us-gaap Cost Of Revenue
CostOfRevenue
4614744
CY2020Q2 us-gaap Costs And Expenses
CostsAndExpenses
7531400
CY2019Q2 us-gaap Costs And Expenses
CostsAndExpenses
7479996
CY2020Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1809407
CY2020Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
630078
CY2020Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1179329
CY2019Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
38028
CY2020Q2 us-gaap Depreciation
Depreciation
194557
CY2019Q2 us-gaap Depreciation
Depreciation
201110
CY2020Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
185605
CY2019Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
231955
CY2020Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
343115
CY2019Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
377654
CY2020Q2 us-gaap Dividends Payable Current
DividendsPayableCurrent
CY2020Q1 us-gaap Dividends Payable Current
DividendsPayableCurrent
722344
CY2020Q2 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
CY2019Q2 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
715899
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.61
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.12
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.61
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.11
CY2020Q2 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2020Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4145034
CY2020Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3996477
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
1281184
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
417509
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
277022
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
329267
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
391988
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
466554
CY2020Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
7482605
CY2020Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
7542558
CY2020Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3163524
CY2020Q2 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-4956
CY2019Q2 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-2867
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3179475
CY2019Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1144731
CY2020Q2 us-gaap Goodwill
Goodwill
729701
CY2020Q1 us-gaap Goodwill
Goodwill
1046944
CY2020Q2 us-gaap Goodwill Gross
GoodwillGross
729701
CY2020Q1 us-gaap Goodwill Gross
GoodwillGross
1046944
CY2020Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
317243
CY2020Q2 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
159000
CY2020Q2 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
68558
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-4846725
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
943784
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1179328
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
232175
CY2020Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-340
CY2019Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
8481
CY2020Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
417979
CY2020Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
418319
CY2020Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
680748
CY2019Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
115667
CY2020Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-476533
CY2019Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
100089
CY2020Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
35453
CY2019Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
28640
CY2020Q2 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-27515
CY2019Q2 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-90248
CY2020Q2 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-340
CY2019Q2 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-185667
CY2020Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
433932
CY2019Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-367824
CY2020Q2 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-12393
CY2019Q2 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
122047
CY2020Q2 us-gaap Indefinite Lived Franchise Rights
IndefiniteLivedFranchiseRights
2915707
CY2020Q1 us-gaap Indefinite Lived Franchise Rights
IndefiniteLivedFranchiseRights
3047688
CY2020Q2 us-gaap Interest Expense
InterestExpense
23562
CY2019Q2 us-gaap Interest Expense
InterestExpense
12398
CY2020Q2 us-gaap Interest Paid Net
InterestPaidNet
13362
CY2019Q2 us-gaap Interest Paid Net
InterestPaidNet
9814
CY2020Q2 us-gaap Inventory Write Down
InventoryWriteDown
544060
CY2020Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2034297
CY2020Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1827767
CY2020Q2 us-gaap Inventory Net
InventoryNet
4140827
CY2020Q1 us-gaap Inventory Net
InventoryNet
3750978
CY2020Q2 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
2355461
CY2020Q1 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
2186652
CY2020Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
291017
CY2020Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
320149
CY2019Q2 us-gaap Inventory Write Down
InventoryWriteDown
CY2020Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
5800
CY2019Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
10179
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2781290
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
552817
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
164223
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
315962
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
437445
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
694755
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
616088
CY2020Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
262846
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
29108126
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
27817388
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
9679151
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
5606822
CY2020Q2 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
3448165
CY2020Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
CY2020Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
948047
CY2020Q1 us-gaap Long Term Notes Payable
LongTermNotesPayable
CY2020Q2 us-gaap Loss Contingency Disclosures
LossContingencyDisclosures
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">NOTE <div style="display: inline; font-style: italic; font: inherit;">14</div> &#x2013; FTD LOSS CONTINGENCY</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">In <div style="display: inline; font-style: italic; font: inherit;"> June 2019, </div>the Company&#x2019;s largest customer, FTD Companies, Inc. and its domestic subsidiaries (&#x201c;FTD&#x201d;), filed for Chapter <div style="display: inline; font-style: italic; font: inherit;">11</div> bankruptcy proceedings. As a part of such bankruptcy proceedings, divisions of FTD&#x2019;s business and certain related assets, including the divisions that the Company has historically sold product to, were sold through an auction to multiple buyers.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">The Company has historically conducted business with FTD under a Gourmet Foods Supplier Agreement (the &#x201c;Supplier Agreement&#x201d;), that among other provisions, provided assurance that custom inventory purchased by the Company and developed specifically for FTD would be purchased by FTD upon termination of the Supplier Agreement. On <div style="display: inline; font-style: italic; font: inherit;"> September 23, 2019, </div>the Company received notice that the bankruptcy court had approved FTD to reject and <div style="display: inline; font-style: italic; font: inherit;">not</div> enforce the Supplier Agreement as part of the proceedings.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">As a result of FTD&#x2019;s bankruptcy, the sale of certain assets, and the court&#x2019;s approval to reject and <div style="display: inline; font-style: italic; font: inherit;">not</div> enforce the terms of the Supplier Agreement, the Company is uncertain if accounts receivable and inventory balances associated with FTD at <div style="display: inline; font-style: italic; font: inherit;"> May 31, 2020 </div>will be realized at their full value, or if any revenue will be received from FTD in the future. During FY <div style="display: inline; font-style: italic; font: inherit;">2020,</div> the Company recognized an estimated loss of <div style="display: inline; font-style: italic; font: inherit;">$230,384</div> associated with inventory specific to FTD as the Company determined that it was probable that a loss on certain inventory would be realized. A potential loss associated with the remaining balances is <div style="display: inline; font-style: italic; font: inherit;">not</div> probable and/or is <div style="display: inline; font-style: italic; font: inherit;">not</div> able to be estimated as of the date of these consolidated financial statements.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">As of <div style="display: inline; font-style: italic; font: inherit;"> May 31, 2020, </div>balances associated with FTD consist of the following:</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div> <table style="margin-right: 20%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">May 31, 2020</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 81%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Ingredients and supplies</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">296,019</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Finished candy</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">20,562</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Accounts receivable</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">79,744</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Reserve for estimated losses</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(198,054</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Total potential loss, contingent upon the bankruptcy proceedings</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">198,271</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> </table> </div></div>
CY2020Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4263021
CY2019Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1061726
CY2020Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-46127
CY2019Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-254836
CY2020Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1598042
CY2019Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1828109
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-3667397
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
711609
CY2020Q2 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
110624
CY2020Q1 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
160700
CY2020Q2 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
124912
CY2020Q1 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
289515
CY2020Q2 us-gaap Notes Payable Current
NotesPayableCurrent
590377
CY2020Q1 us-gaap Notes Payable Current
NotesPayableCurrent
CY2020Q2 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
5
CY2020Q2 us-gaap Number Of Stores
NumberOfStores
428
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-4828963
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
946003
CY2020Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
212063
CY2019Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
238666
CY2020Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
2518444
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
803106
CY2020Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
803861
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1715338
CY2020Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1894904
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2518444
CY2020Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2698765
CY2020Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.034
CY2020Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y255D
CY2020Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
294434
CY2020Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
316751
CY2020Q2 us-gaap Other Assets Current
OtherAssetsCurrent
397311
CY2020Q1 us-gaap Other Assets Current
OtherAssetsCurrent
409703
CY2020Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
56263
CY2020Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
56262
CY2020Q2 us-gaap Other Noncash Expense
OtherNoncashExpense
158834
CY2019Q2 us-gaap Other Noncash Expense
OtherNoncashExpense
166649
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-17762
CY2019Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2219
CY2020Q2 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
CY2019Q2 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-312
CY2020Q2 us-gaap Payments Of Dividends
PaymentsOfDividends
722344
CY2019Q2 us-gaap Payments Of Dividends
PaymentsOfDividends
715179
CY2020Q2 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
41464
CY2019Q2 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
CY2020Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
22488
CY2019Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
283548
CY2020Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
250000
CY2020Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
250000
CY2020Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q2 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
17825
CY2019Q2 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
28400
CY2020Q2 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
3448165
CY2019Q2 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
CY2020Q2 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
1537200
CY2019Q2 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
CY2020Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
18246665
CY2020Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
18657351
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5703584
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5938013
CY2020Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1468815
CY2019Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
81283
CY2020Q2 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
CY2019Q2 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
346547
CY2020Q2 us-gaap Restructuring Costs
RestructuringCosts
68558
CY2019Q2 us-gaap Restructuring Costs
RestructuringCosts
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
8222163
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
11889560
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2702437
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8425999
CY2020Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
146360
CY2020Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
183708
CY2020Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
171978
CY2020Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
139353
CY2020Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
126070
CY2020Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
359781
CY2020Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
1127250
CY2020Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2020Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2020Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2020Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2020Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2020Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2020Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
474090
CY2019Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
556651
CY2020Q2 us-gaap Share Based Compensation
ShareBasedCompensation
143718
CY2019Q2 us-gaap Share Based Compensation
ShareBasedCompensation
231254
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
0
CY2014Q3 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
3000000
CY2020Q2 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
638000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
15831832
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
19355511
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
20616556
CY2020Q2 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0
CY2019Q2 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0
CY2020Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
CY2019Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
272286
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6058851
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6234564
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6058851
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5962278

Files In Submission

Name View Source Status
0001437749-20-015388-index-headers.html Edgar Link pending
0001437749-20-015388-index.html Edgar Link pending
0001437749-20-015388.txt Edgar Link pending
0001437749-20-015388-xbrl.zip Edgar Link pending
ex_193903.htm Edgar Link pending
ex_193904.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rmcf-20200531.xml Edgar Link completed
rmcf-20200531.xsd Edgar Link pending
rmcf-20200531_cal.xml Edgar Link unprocessable
rmcf-20200531_def.xml Edgar Link unprocessable
rmcf-20200531_lab.xml Edgar Link unprocessable
rmcf-20200531_pre.xml Edgar Link unprocessable
rmcfd20200630_10q.htm Edgar Link pending
rmcfd20200630_10qimg001.jpg Edgar Link pending
Show.js Edgar Link pending